当前位置:首页 - 行情中心 - 丸美生物(603983) - 财务分析 - 现金流量表

丸美生物

(603983)

  

流通市值:97.44亿  总市值:97.44亿
流通股本:4.01亿   总股本:4.01亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,280,752,233.071,697,349,069.46898,352,585.353,922,166,113.16
  收到的税费返还291,677.36515.56515.56-
  收到其他与经营活动有关的现金8,688,585.4758,664,620.9332,046,839.6676,313,507.15
  经营活动现金流入小计2,289,732,495.91,756,014,205.95930,399,940.573,998,479,620.31
  购买商品、接受劳务支付的现金652,750,536.24480,248,306.99254,264,870.41,017,504,988.33
  支付给职工以及为职工支付的现金221,755,901.33152,195,644.6883,750,417.21266,436,208.27
  支付的各项税费171,304,720.9126,308,270.9157,691,416.9267,994,938.88
  支付其他与经营活动有关的现金1,284,904,172.27918,171,277.36497,499,729.382,172,667,082.51
  经营活动现金流出小计2,330,715,330.741,676,923,499.94893,206,433.893,724,603,217.99
  经营活动产生的现金流量净额-40,982,834.8479,090,706.0137,193,506.68273,876,402.32
二、投资活动产生的现金流量:
  收回投资收到的现金220,420,978.54214,385,978.5457,270,000140,000,000
  取得投资收益收到的现金24,858,799.5624,541,610.971,002,824.333,771,504.65
  处置固定资产、无形资产和其他长期资产收回的现金净额---24,346.17
  处置子公司及其他营业单位收到的现金净额110,286.4110,286.4110,286.4118,918.4
  收到的其他与投资活动有关的现金54,650,000--49,527,540
  投资活动现金流入小计300,040,064.5239,037,875.9158,383,110.73193,442,309.22
  购建固定资产、无形资产和其他长期资产支付的现金133,970,032.31104,342,274.7577,560,025.82205,247,767.2
  投资支付的现金24,999,854.8424,999,854.8424,999,854.84302,130,000
  支付其他与投资活动有关的现金57,000,000---
  投资活动现金流出小计215,969,887.15129,342,129.59102,559,880.66507,377,767.2
  投资活动产生的现金流量净额84,070,177.35109,695,746.32-44,176,769.93-313,935,457.98
三、筹资活动产生的现金流量:
  吸收投资收到的现金700,000700,000700,000-
  其中:子公司吸收少数股东投资收到的现金700,000700,000700,000-
  收到其他与筹资活动有关的现金574,418,841.94404,794,253.05121,493,293.331,437,822,791.35
  筹资活动现金流入小计575,118,841.94405,494,253.05122,193,293.331,437,822,791.35
  偿还债务支付的现金---150,000,000
  分配股利、利润或偿付利息支付的现金100,407,435.7149,009.38-301,341,400.93
  其中:子公司支付给少数股东的股利、利润164,020.51--455,984.26
  支付其他与筹资活动有关的现金578,192,874.95398,062,936.19135,979,845.261,584,214,907.56
  筹资活动现金流出小计678,600,310.65398,211,945.57135,979,845.262,035,556,308.49
  筹资活动产生的现金流量净额-103,481,468.717,282,307.48-13,786,551.93-597,733,517.14
四、汇率变动对现金及现金等价物的影响-111,732.73-42,086.02-17,794.29-6,647.49
五、现金及现金等价物净增加额-60,505,858.93196,026,673.79-20,787,609.47-637,799,220.29
  加:期初现金及现金等价物余额941,260,789.65941,260,789.65941,260,789.651,579,060,009.94
  期末现金及现金等价物余额880,754,930.721,137,287,463.44920,473,180.18941,260,789.65
补充资料:
  净利润-156,955,422.13-246,742,825.83
  资产减值准备-2,110,173.95-3,287,597.39
  固定资产和投资性房地产折旧-25,767,363.82-42,043,888.55
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-25,767,363.82-42,043,888.55
  无形资产摊销-7,001,563.96-19,762,865.84
  长期待摊费用摊销-2,498,283.95-973,479.91
  处置固定资产、无形资产和其他长期资产的损失----377,398.06
  固定资产报废损失-339,798.21-259,847.08
  公允价值变动损失-4,500,110.53--432,554.85
  财务费用-34,506.38-3,808,356.01
  投资损失--63,967,148.09--27,553,438.99
  递延所得税--16,130,245.87--16,995,221.31
  其中:递延所得税资产减少--21,466,720.96--18,982,813.59
    递延所得税负债增加-5,336,475.09-1,987,592.28
  存货的减少-34,645,240.97--16,978,963.04
  经营性应收项目的减少-8,631,245.96-54,365,901.07
  经营性应付项目的增加--83,493,244.3--36,548,056.92
  现金的期末余额-1,137,287,463.44-941,260,789.65
  减:现金的期初余额-941,260,789.65-1,579,060,009.94
  现金及现金等价物的净增加额-196,026,673.79--637,799,220.29
公告日期2026-10-312026-08-292026-04-302026-04-01
审计意见(境内)标准无保留意见
TOP↑